Bio Availability or Bio Equivalence study [Design Issues]

posted by jag009  – NJ, 2016-05-10 01:09 (3198 d 20:36 ago) – Posting: # 16285
Views: 8,366

Hi Ohlbe

❝ Do you think an extended release formulation can be bioequivalent to an immediate release fomulation ?


It is possible if he is talking about a ER q.d. vs IR b.i.d (or t.i.d, or q.i.d.) formulation under the same total daily dose where in some cases one might want to demonstrate bioquivalence between the two products. Example, Ultram ER is bioequivalent to Tramadol IR (given as qid)....

John

Complete thread:

UA Flag
Activity
 Admin contact
23,379 posts in 4,913 threads, 1,661 registered users;
238 visitors (0 registered, 238 guests [including 16 identified bots]).
Forum time: 20:45 CET (Europe/Vienna)

Science is what you know.
Philosophy is what you don’t know.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5